Software - Application
Compare Stocks
2 / 10Stock Comparison
CREX vs DLHC
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
CREX vs DLHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Specialty Business Services |
| Market Cap | $39M | $83M |
| Revenue (TTM) | $44M | $293M |
| Net Income (TTM) | $-10M | $-4M |
| Gross Margin | 43.1% | 14.4% |
| Operating Margin | -22.6% | 2.5% |
| Forward P/E | — | 60.8x |
| Total Debt | $14M | $145M |
| Cash & Equiv. | $1M | $125K |
CREX vs DLHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Creative Realities,… (CREX) | 100 | 49.1 | -50.9% |
| DLH Holdings Corp. (DLHC) | 100 | 77.4 | -22.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CREX vs DLHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CREX is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.09
- Rev growth 12.6%, EPS growth 2.9%, 3Y rev CAGR 40.2%
- 12.6% revenue growth vs DLHC's -13.0%
DLHC carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 24.0% 10Y total return vs CREX's -79.4%
- Lower volatility, beta 0.82, current ratio 1.00x
- Beta 0.82, current ratio 1.00x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.6% revenue growth vs DLHC's -13.0% | |
| Value | Better valuation composite | |
| Quality / Margins | -1.5% margin vs CREX's -21.5% | |
| Stability / Safety | Beta 0.82 vs CREX's 1.09 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +130.4% vs DLHC's +41.5% | |
| Efficiency (ROA) | -1.6% ROA vs CREX's -14.8%, ROIC 4.7% vs 1.8% |
CREX vs DLHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CREX vs DLHC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DLHC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DLHC is the larger business by revenue, generating $293M annually — 6.6x CREX's $44M. DLHC is the more profitable business, keeping -1.5% of every revenue dollar as net income compared to CREX's -21.5%. On growth, CREX holds the edge at -27.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $44M | $293M |
| EBITDAEarnings before interest/tax | -$5M | $25M |
| Net IncomeAfter-tax profit | -$10M | -$4M |
| Free Cash FlowCash after capex | -$3M | $19M |
| Gross MarginGross profit ÷ Revenue | +43.1% | +14.4% |
| Operating MarginEBIT ÷ Revenue | -22.6% | +2.5% |
| Net MarginNet income ÷ Revenue | -21.5% | -1.5% |
| FCF MarginFCF ÷ Revenue | -6.6% | +6.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -27.0% | -33.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -19.2% | -4.0% |
Valuation Metrics
DLHC leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, DLHC's 6.7x EV/EBITDA is more attractive than CREX's 10.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $39M | $83M |
| Enterprise ValueMkt cap + debt − cash | $52M | $228M |
| Trailing P/EPrice ÷ TTM EPS | -10.91x | 60.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 10.36x | 6.71x |
| Price / SalesMarket cap ÷ Revenue | 0.77x | 0.24x |
| Price / BookPrice ÷ Book value/share | 1.52x | 0.73x |
| Price / FCFMarket cap ÷ FCF | 67.29x | 3.61x |
Profitability & Efficiency
DLHC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DLHC delivers a -4.0% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-36 for CREX. CREX carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to DLHC's 1.28x. On the Piotroski fundamental quality scale (0–9), DLHC scores 5/9 vs CREX's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -35.8% | -4.0% |
| ROA (TTM)Return on assets | -14.8% | -1.6% |
| ROICReturn on invested capital | +1.8% | +4.7% |
| ROCEReturn on capital employed | +2.1% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.55x | 1.28x |
| Net DebtTotal debt minus cash | $13M | $145M |
| Cash & Equiv.Liquid assets | $1M | $125,000 |
| Total DebtShort + long-term debt | $14M | $145M |
| Interest CoverageEBIT ÷ Interest expense | -4.59x | 0.46x |
Total Returns (Dividends Reinvested)
CREX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CREX five years ago would be worth $10,054 today (with dividends reinvested), compared to $5,601 for DLHC. Over the past 12 months, CREX leads with a +130.4% total return vs DLHC's +41.5%. The 3-year compound annual growth rate (CAGR) favors CREX at 12.0% vs DLHC's -17.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +33.0% | +2.7% |
| 1-Year ReturnPast 12 months | +130.4% | +41.5% |
| 3-Year ReturnCumulative with dividends | +40.5% | -44.1% |
| 5-Year ReturnCumulative with dividends | +0.5% | -44.0% |
| 10-Year ReturnCumulative with dividends | -79.4% | +24.0% |
| CAGR (3Y)Annualised 3-year return | +12.0% | -17.6% |
Risk & Volatility
Evenly matched — CREX and DLHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
DLHC is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than CREX's 1.09 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CREX currently trades 85.3% from its 52-week high vs DLHC's 70.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.09x | 0.82x |
| 52-Week HighHighest price in past year | $4.35 | $8.10 |
| 52-Week LowLowest price in past year | $1.60 | $3.95 |
| % of 52W HighCurrent price vs 52-week peak | +85.3% | +70.7% |
| RSI (14)Momentum oscillator 0–100 | 56.8 | 45.4 |
| Avg Volume (50D)Average daily shares traded | 32K | 8K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
DLHC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CREX leads in 1 (Total Returns). 1 tied.
CREX vs DLHC: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is CREX or DLHC a better buy right now?
For growth investors, Creative Realities, Inc.
(CREX) is the stronger pick with 12. 6% revenue growth year-over-year, versus -13. 0% for DLH Holdings Corp. (DLHC). DLH Holdings Corp. (DLHC) offers the better valuation at 60. 8x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CREX or DLHC?
Over the past 5 years, Creative Realities, Inc.
(CREX) delivered a total return of +0. 5%, compared to -44. 0% for DLH Holdings Corp. (DLHC). Over 10 years, the gap is even starker: DLHC returned +24. 0% versus CREX's -79. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CREX or DLHC?
By beta (market sensitivity over 5 years), DLH Holdings Corp.
(DLHC) is the lower-risk stock at 0. 82β versus Creative Realities, Inc. 's 1. 09β — meaning CREX is approximately 32% more volatile than DLHC relative to the S&P 500. On balance sheet safety, Creative Realities, Inc. (CREX) carries a lower debt/equity ratio of 55% versus 128% for DLH Holdings Corp. — giving it more financial flexibility in a downturn.
04Which is growing faster — CREX or DLHC?
By revenue growth (latest reported year), Creative Realities, Inc.
(CREX) is pulling ahead at 12. 6% versus -13. 0% for DLH Holdings Corp. (DLHC). On earnings-per-share growth, the picture is similar: Creative Realities, Inc. grew EPS 2. 9% year-over-year, compared to -81. 5% for DLH Holdings Corp.. Over a 3-year CAGR, CREX leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CREX or DLHC?
DLH Holdings Corp.
(DLHC) is the more profitable company, earning 0. 4% net margin versus -6. 9% for Creative Realities, Inc. — meaning it keeps 0. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DLHC leads at 4. 9% versus 1. 8% for CREX. At the gross margin level — before operating expenses — CREX leads at 47. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CREX or DLHC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is CREX or DLHC better for a retirement portfolio?
For long-horizon retirement investors, DLH Holdings Corp.
(DLHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82)). Both have compounded well over 10 years (DLHC: +24. 0%, CREX: -79. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CREX and DLHC?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.